Termination by Celgene Pursuant to Section. 11.3 or 11.4. In the event of termination of this Agreement with respect to any one or more Programs conducted hereunder or in its entirety by Celgene pursuant to Sections 11.3 or 11.4, notwithstanding anything contained in this Agreement to the contrary, upon the effective date of such termination:
Appears in 3 contracts
Samples: License Agreement (Vividion Therapeutics, Inc.), License Agreement (Vividion Therapeutics, Inc.), License Agreement (Agios Pharmaceuticals Inc)
Termination by Celgene Pursuant to Section. 11.3 11.2 or 11.4. In the event of termination of this Agreement in its entirety or in part with respect to any one or more Programs conducted hereunder or in its entirety by Celgene pursuant to Sections 11.3 Section 11.2 or 11.4, notwithstanding anything contained in this Agreement to the contrary, upon the effective date of such termination:
Appears in 1 contract
Samples: Master Collaboration Agreement
Termination by Celgene Pursuant to Section. 11.3 13.2 or 11.413.4. In the event of termination of this Agreement with respect to any one or more Programs conducted hereunder or in its entirety is terminated by Celgene pursuant to Sections 11.3 Section 13.2 or 11.4, notwithstanding anything contained in this Agreement to the contrary13.4, upon the effective date of such termination:
Appears in 1 contract
Samples: Exclusive License and Collaboration Agreement (BeiGene, Ltd.)
